# Tadalafil and Sildenafil for Duchenne Muscular Dystrophy

> **NCT01359670** · EARLY_PHASE1 · COMPLETED · sponsor: **Cedars-Sinai Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Sildenafil

## Key facts

- **NCT ID:** NCT01359670
- **Lead sponsor:** Cedars-Sinai Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2020-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01359670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01359670, "Tadalafil and Sildenafil for Duchenne Muscular Dystrophy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01359670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*